Trasylol Stroke Lawsuit

FDA Recalls Trasylol – Cites Increased Strokes and Blood Clots

On November 5, 2007, the FDA recalls Trasylol from the market due to seriously increased risks of strokes, blood clots, heart attacks, kidney damage and kidney failure (see FDA Trasylol Recall). The FDA recall of Trasylol stems from Dr. Dennis Mangano's latest findings, in which he concluded that 22,000 cardiac patients could have been saved if Trasylol had been taken off the market in January 2006 when his Trasylol side effects study was first published. Dr. Dennis Mangano's study found that Trasylol increased the risk of Trasylol-related strokes, Trasylol-related heart attacks, Trayslol-related kidney damage, kidney failure, and death in heart bypass patients. It is estimated that Trasylol damages costs over $1 billion in health care every year. Most heart surgery patients don't know if they were given Trasylol during their open heart surgery until an investigation into their records is conducted after a Trasylol stroke or heart attack side effect is discovered.

Bayer's Failure to Disclose Increased Trasylol Stroke Data to FDA

On September 21, 2006 the FDA's Cardiovascular and Renal Drug Advisory Committee met to evaluate current data regarding Trasylol side effects. On September 29, 2006, the FDA issued a public health advisory stating that it had new information that Bayer failed to disclose an earlier study that it had conducted involving 67,000 heart surgery patients. Preliminary review of this study suggested that Trasylol side effects included higher risks for stroke, congestive heart failure, kidney damage, and death. Bayer failed to disclose the existence of the Trasylol study during the Advisory Committee on September 21, 2006 and continued to market Trasylol for use in cardiac procedures knowing about increased risks of Trasylol heart attacks and strokes.

Risks of a Trasylol Stroke and Blood Clot

A Trasylol stroke is an injury caused by lack of blood supply to the brain. A stroke is a serious medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. Symptoms of stroke are:

• Sudden numbness or weakness of the face, arm or leg (especially on one side)
• Sudden confusion, trouble speaking or understanding speech
• Sudden vision loss or trouble seeing in one or both eyes
• Sudden trouble walking, dizziness, loss of balance or coordination
• Sudden severe headache with no known cause

The study to establish the risk for Trasylol stroke and other adverse side effects examined over 4,000 heart surgery patients who were given either Trasylol, alternative medications or no medication at all. This Trasylol medical study is very disturbing especially since 1000's of Trasylol strokes, heart attacks and kidney failures have been taking place almost unchecked for 13 years without the intervention of the FDA or a mandated FDA recall of Trasylol.

Trasylol Stroke Lawsuit

If you or a loved one has suffered a stroke, blood clot, heart attack, heart damage, kidney damage, or kidney failure after a cardiac catherization, a heart bypass surgery or any other cardiac operation, then call our offices to discuss your legal rights to a possible Trasylol stroke lawsuit. Talk to a Board Certified Personal Injury Trial Lawyer and get your questions answered. Contact our law firm today.

Click Here for a Free Trasylol Case Evaluation